98280-12-7 Usage
General Description
4-Bromo-(2-hydroxyethyl)-pyridine is a chemical compound with the molecular formula C7H8BrNO. It is a derivative of pyridine and contains a bromine atom, a hydroxyethyl group, and a pyridine ring. 4-Bromo-(2-hydroxyethyl)-pyridine is commonly used in organic synthesis as a building block for the preparation of various pharmaceuticals, agrochemicals, and other fine chemicals. It can also be utilized as a versatile intermediate in the synthesis of heterocyclic compounds and has potential applications in the field of medicinal chemistry. Additionally, it may have biological activity and can be used as a scaffold for designing new therapeutic agents. Overall, 4-Bromo-(2-hydroxyethyl)-pyridine is a valuable chemical with diverse applications in chemical and pharmaceutical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 98280-12-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,2,8 and 0 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 98280-12:
(7*9)+(6*8)+(5*2)+(4*8)+(3*0)+(2*1)+(1*2)=157
157 % 10 = 7
So 98280-12-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H8BrNO/c8-6-1-3-9-7(5-6)2-4-10/h1,3,5,10H,2,4H2
98280-12-7Relevant articles and documents
BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS
-
Page/Page column 226; 227, (2018/03/25)
Disclosed are compounds of Formula (I) to (VIII): (I) (II) (III) (IV) (V) (VI) (VII) (VIII); or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate or prodrug thereof, wherein R3 is a bicyclic heteroaryl group substituted with zero to 3 R3a; and R1, R2, R3a, R4, and n are defined herein. Also disclosed are methods of using such compounds as PAR4 inhibitors, and pharmaceutical compositions comprising such compounds. These compounds are useful in inhibiting or preventing platelet aggregation, and are useful for the treatment of a thromboembolic disorder or the primary prophylaxis of a thromboembolic disorder.
